To elucidate the function of IER5 in glioma patients, we performed GSEA and found that pathways related to p53, MTORC1 signaling, angiogenesis, apoptosis, the cell cycle, KRAS signaling, and response to ionizing radiation were enriched differentially in the IER5-high expression phenotype. The gene discussed is KRAS; the disease is glioma.